March 15, 2021

S2-E14 — NASH-TAG Session 4 Summary: Basic Science and Promising Drugs on the Horizon

Naim Alkhouri and Jörn Schattenberg join Roger and Donna to review the closing session of NASH-TAG 2021, a potpourri of basic science and review of promising drugs earlier in development.

The Saturday afternoon closing session of NASH-TAG 2021 spends half its time discussing basic science issues and the other half with BioPharma company drug developers discussing their promising drugs in development. Last year, this session yielded some real fireworks! On Sunday, join SurfingNASH to sort out how what the data means, how the pieces fit together and what questions will require more exploration. If you send us any questions emerging from Session #4 or the podcast, we will review them in our NASH-TAG wrap-up episode next week.

S2-E14 — NASH-TAG Session 4 Summary: Basic Science and Promising Drugs on the Horizon

The NASH Tsunami In Diabetes

Listen Now

S4-23 – Stephen Harrison on Challenges and Opportunities in NASH Drug Development

S4-22 – PART 1: FDA ADCOM Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis Due to NASH

S4-21 – Surfing NASH Previews EASL Congress 2023

S4-20.6 – From the Vault: Discussing NITs and Final Thoughts on NAFLD Summit

S4-20.5 – Harnessing the Strengths of the Patient Advocate Community

S4-20.4 – Donna Cryer’s Call to Action for Patient Advocacy in the NASH Community

S4-20.3 – Generating and Promoting the Data to Demonstrate Patient Needs

S4-20.2 – Listening to Both Sides: Allied Health for Patient Empowerment

S4-20.1 – Who is going to be the Larry Kramer of NASH?

S4-20 – Leveraging Patient Voice and Needs in the NASH Community

Experience Nudge Learning! Interested in a new way of learning?

S2-E14 — NASH-TAG Session 4 Summary: Basic Science and Promising Drugs on the Horizon

The NASH Tsunami In Diabetes

Categories for NASH Tsunami

Listen Now

Experience Nudge Learning! Interested in a new way of learning?